Home/News/News details

Neuromyelitis Optica Drug Market Analysis- Size, Share, overview, scope, Revenue, Gross Margin, Segment and Forecast 2021

Apr 26, 2017

Neuromyelitis Optica Drug Market Analysis- Size, Share, overview, scope, Revenue, Gross Margin, Segment and Forecast 2021

Neuromyelitis Optica (NMO) is also referred as Neuromyelitis Optica Spectrum Disorder (NMOSD) and Devic’s disease. It is an atypical autoimmune demyelinating disorder in which the immune system cells and antibodies attack the optic nerve and the spinal cord. Earlier NMO was considered to be type of multiple sclerosis (MS), however it is now characterized as a unique disease along with different pathology and immunopathogenesis, that do not react to traditional multiple sclerosis immunomodulators such as interferons. The optic nerves which get damaged result in swelling and inflammation and eventually loss of vision. While, the severed spinal cord leads to weakness and paralysis in the legs or arms, loss of sensation and bowel and bladder problems. The cause for NMO in a person is thought to be owing to a specific attack on the aquaporin-4 (AQP4) water channel that is positioned within the optic nerves and the spinal cord. Aquaporins are proteins that are responsible for channeling water across membranes of the cell. More than 70% of patients having NMO have antibody biomarker in the blood called anti-AQP4 or NMO-IgG antibody.

Get Free Sample Copy of Neuromyelitis Optica Drug Market Report @ http://www.globalinforeports.com/request-sample/186933

The Global Neuromyelitis Optica Drug Industry is predicted to grow and garner maximum revenue share and resister itself at a substantial CAGR during the forecast period. Neuromyelitis Optica happens is almost every region of the world and might have more prevalence in few populations such as Africans, Asians and Native Americans. It has been estimated that approximately 4,000 individuals with NMO are present in the United States alone and a quarter-million across the globe. Presently, there are no medicinal drugs developed that could entirely cure this disorder, in its place medicines like mycophenolate mofetil (CellCept), rituximab (Rituxan), mycophenolate, azathioprine (Imuran, Azasan), etc., are suggested for maintaining the on-going therapy. One of the major key factors contributing to the lucrative growth of this market industry is the increasing worldwide population. Also, prevalence of NMO in women is more than men, i.e., nearly 80% higher. Lastly, escalating elderly population is also accountable for the market growth.

Browse full Report with table of contents and data tables For Neuromyelitis Optica Drug Market Report @http://www.globalinforeports.com/report/global-neuromyelitis-optica-drug-market-by-manufacturers-regions-type-and-application-forecast-to-2021

The key market players of the global neuromyelitis optica drug market are Intas, NANG KUANG, FRESENIUS, Baxter, SANDOZ, Grifols, Pfizer, Octapharma, TEVA, Tianjin Kingyork, Gyjtrs, CBOP, and CSL. The end-user applications of this industry’s market are remission prophylactic treatment and acute attack. Geographically, the market is regionally split into North America (USA, Canada and Mexico), Europe (Germany, France, UK, Russia and Italy), Asia-Pacific (China, Japan, Korea, India and Southeast Asia), South America, Middle East and Africa. Lastly, the product type of this market is segmented into price range, production market share, and cost.

Ask for Discount @ http://www.globalinforeports.com/request-sample/186933

Some points from TOC:-

3 Global Neuromyelitis Optica Drug Market Competition, by Manufacturer

3.1 Global Neuromyelitis Optica Drug Sales and Market Share by Manufacturer

3.2 Global Neuromyelitis Optica Drug Revenue and Market Share by Manufacturer

3.3 Market Concentration Rate

3.3.1 Top 3 Neuromyelitis Optica Drug Manufacturer Market Share

3.3.2 Top 6 Neuromyelitis Optica Drug Manufacturer Market Share

3.4 Market Competition Trend

4 Global Neuromyelitis Optica Drug Market Analysis by Regions

4.1 Global Neuromyelitis Optica Drug Sales, Revenue and Market Share by Regions

4.1.1 Global Neuromyelitis Optica Drug Sales by Regions (2011-2016)

4.1.2 Global Neuromyelitis Optica Drug Revenue by Regions (2011-2016)

4.2 North America Neuromyelitis Optica Drug Sales and Growth (2011-2016)

4.3 Europe Neuromyelitis Optica Drug Sales and Growth (2011-2016)

4.4 Asia-Pacific Neuromyelitis Optica Drug Sales and Growth (2011-2016)

4.5 South America Neuromyelitis Optica Drug Sales and Growth (2011-2016)

4.6 Middle East and Africa Neuromyelitis Optica Drug Sales and Growth (2011-2016)

5 North America Neuromyelitis Optica Drug by Countries

5.1 North America Neuromyelitis Optica Drug Sales, Revenue and Market Share by Countries

5.1.1 North America Neuromyelitis Optica Drug Sales by Countries (2011-2016)

5.1.2 North America Neuromyelitis Optica Drug Revenue by Countries (2011-2016)

5.2 USA Neuromyelitis Optica Drug Sales and Growth (2011-2016)

5.3 Canada Neuromyelitis Optica Drug Sales and Growth (2011-2016)

5.4 Mexico Neuromyelitis Optica Drug Sales and Growth (2011-2016)

6 Europe Neuromyelitis Optica Drug by Countries

6.1 Europe Neuromyelitis Optica Drug Sales, Revenue and Market Share by Countries

6.1.1 Europe Neuromyelitis Optica Drug Sales by Countries (2011-2016)

6.1.2 Europe Neuromyelitis Optica Drug Revenue by Countries (2011-2016)

6.2 Germany Neuromyelitis Optica Drug Sales and Growth (2011-2016)

6.3 UK Neuromyelitis Optica Drug Sales and Growth (2011-2016)

6.4 France Neuromyelitis Optica Drug Sales and Growth (2011-2016)

6.5 Russia Neuromyelitis Optica Drug Sales and Growth (2011-2016)

6.6 Italy Neuromyelitis Optica Drug Sales and Growth (2011-2016)

Enquiry before Buying @ http://www.globalinforeports.com/send-an-enquiry/186933

About Us:

GIR Market Research is a company that simplifies how analysts and decision makers get industry data for their business. Our unique colossal technology has been developed to offer refined search capabilities designed to exploit the long tail of free market research whilst eliminating irrelevant results. GIR Market Research is the collection of market intelligence products and services on the Web. We offer reports and update our collection daily to provide you with instant online access to the world’s most complete and current database of expert insights on global industries, companies, products, and trends.

Contact us:

+1-888-376-9998 (US)

Email- sales@globalinforeports.com

Web- http://www.globalinforeports.com

Blogs- http://www.globalinforeports.com/blog

Connect with us: Twitter | Facebook

footer pattern

All Copyrights reserve worldhealthcarenews.biz 2017.